#TakeAction – April 24, 2019

Good morning. Let’s #TakeAction for Wednesday, April 24, 2019.

🔶 Ask Rep. Schrier to Cosponsor the Assault Weapons Ban of 2019
🔶 Support S.270, the Paycheck Fairness Act
🔶 Ask Rep. Schrier to Cosponsor the Medicare Negotiation and Competitive Licensing Act

1. (ACTION) Ask Rep. Schrier to Cosponsor the Assault Weapons Ban of 2019

2. (ACTION) Support S.270, the Paycheck Fairness Act

  • Date: On-going
  • Action: Call Senators Murray & Cantwell, ask them to support S.270 in the Senate.
  • Background: This bill likely won’t get consideration in the Senate during this Congress. But we need to do everything we can to give maximum visibility to this issue and to force Republicans to vote on the record on it.
  • Source: Indivisible: https://indivisible.org/resource/hr-7-paycheck-fairness-act

3. (ACTION) Ask Rep. Schrier to Cosponsor the Medicare Negotiation and Competitive Licensing Act

  • Date: On-going
  • Action: Call Rep. Schrier and urge her to cosponsor H.R.1046.
  • Background: This bill lifts the restrictions that currently prevent Medicare from negotiating with drug companies, but just as importantly it would give Medicare the leverage it needs to negotiate effectively without putting patients at risk. Here’s how it would work:
    • Under H.R. 1046, the Secretary of Health and Human Services would be required to negotiate prices for covered Medicare Part D drugs (which is most drugs). This would help to bring down spending on prescription drugs by billions of dollars, since Medicare Part D has a tremendous amount of purchasing power.
    • If the negotiations don’t arrive at an appropriate price, the Secretary would be required to issue a “competitive license.” A competitive license means generic producers of drugs would be allowed to manufacture competitors to name brand drugs when the drug company that owns the patent refuses to responsibly negotiate with Medicare. This competition would subsequently bring down the price of the drug for patients.
    • This approach would put drug companies’ monopolies in the crosshairs—not a patient’s access to medicine. Whether companies are willing to negotiate their prices down or have to deal with generic competition, patients will come out paying lower prices.
  • Source: Indivisible: https://indivisible.org/…/hr-1046-act-now-bring-drug…

**CALENDAR**
We are posting more and more events (both for our group and outside of it) on our calendar. Check it out! http://www.indivisible-wa8.com/calendar/

**EMAIL**
Friends not on FB and want to join our efforts? Sign up for email: http://eepurl.com/cChJwD

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Bitnami